RNS Number : 1210H
NMC Health Plc
23 March 2020
TR-1: S
tandard form for notification of major holdings
|
NOTIFICATION OF MAJOR HOLDINGS
(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
i
|
|
|
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached
ii
:
|
NMC Health plc
|
|
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
|
|
Non-UK issuer
|
|
|
2. Reason for the notification
(please mark the appropriate box or boxes with an "X")
|
|
An acquisition or disposal of voting rights
|
X
|
|
An acquisition or disposal of financial instruments
|
|
|
An event changing the breakdown of voting rights
|
|
|
Other (please specify)iii:
|
|
|
3. Details of person subject to the notification obligation
iv
|
|
Name
|
The Capital Group Companies, Inc. ("CGC")
|
|
City and country of registered office (if applicable)
|
Los Angeles, CA 90071, USA
|
|
4. Full name of shareholder(s)
(if different from 3.)
v
|
|
Name
|
|
|
City and country of registered office (if applicable)
|
|
|
5. Date on which the threshold was crossed or reached
vi
:
|
17 March 2020
|
|
6. Date on which issuer notified (DD/MM/YYYY):
|
18 March 2020
|
|
7. Total positions of person(s) subject to the notification obligation
|
|
|
% of voting rights attached to shares (total of 8. A)
|
% of
voting rights through
financial instruments
(total of 8.B 1 + 8.B 2)
|
Total of both in % (8.A + 8.B)
|
Total number of voting rights of issuer
vii
|
|
Resulting situation on the date on which threshold was crossed or reached
|
11.0115
%
|
0.2012
%
|
11.2127
%
|
208,703,861
|
|
Position of previous notification (if
applicable)
|
12.0361
%
|
0.0000
%
|
12.0361
%
|
|
|
|
|
|
|
|
|
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
viii
|
|
A: Voting rights attached to shares
|
|
Class/type of
shares
ISIN code (if possible)
|
Number of voting rights
ix
|
% of voting rights
|
|
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
|
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
|
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
|
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
|
|
Ordinary Shares (ISIN: GB00B7FC0762)
|
|
23,401,373
|
|
11.2127
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. A
|
23,401,373
|
11.2127
%
|
|
|
|
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
|
|
Type of financial instrument
|
Expiration
date
x
|
Exercise/
Conversion Period
xi
|
Number of voting rights that may be acquired if the instrument is
exercised/converted.
|
% of voting rights
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. B 1
|
|
|
|
|
|
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
|
|
Type of financial instrument
|
Expiration
date
x
|
Exercise/
Conversion Period
xi
|
Physical or cash
settlement
xii
|
Number of voting rights
|
% of voting rights
|
|
Rights to recall lent shares
|
N/A
|
N/A
|
Physical settlement
|
420,000
|
0.2012
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8.B.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. Information in relation to the person subject to the notification obligation
(please mark the
applicable box with an "X")
|
|
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
xiii
|
|
|
Full
chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv
(please add additional rows as necessary)
|
X
|
|
Name
xv
|
% of voting rights if it equals or is higher than the notifiable threshold
|
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
|
Total of both if it equals or is higher than the notifiable threshold
|
|
The Capital Group Companies, Inc.
Holdings by CG Management companies are set out below
:
|
11.0115
%
|
0.2012
%
|
11.2127
%
|
|
• Capital Research and Management Company1
|
11.0115
%
|
0.2012
%
|
11.2127
%
|
|
EUROPACIFIC GROWTH FUND
("EUPAC")
2
|
6.8366
%
|
0.0000
%
|
6.8366
%
|
|
1
Subsidiary of The Capital Group Companies, Inc.
2
Mutual fund managed by Capital Research and Management Company.
|
|
10.
In case of proxy voting, please identify:
|
|
Name of the proxy holder
|
|
|
The number and % of voting rights held
|
|
|
The date until which the voting rights will be held
|
|
|
|
|
11. Additional information
xvi
|
|
The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of four investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl and Capital International K.K. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.
Neither CGC nor any of its affiliates own shares of your company for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.
|
|
|
|
|
|
|
Place of completion
|
Los Angeles, CA, USA
|
|
Date of completion
|
18 March 2020
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
HOLSEFEFEESSESD